Rising Tide Foundation for Clinical Cancer Research (RTFCCR) is a charitable non‑profit organization founded in 2010 in Schaffhausen, Switzerland, dedicated to funding innovative clinical cancer research and interventional trials that improve outcomes and quality of life for people with cancer globally.
Mission and Purpose
RTFCCR’s mission is to support patient‑centred clinical research that delivers measurable benefits to cancer patients within a few years. The foundation prioritizes interventional clinical trials (Phase I–III) designed to optimize treatment options, reduce disease and treatment burden, and advance early detection and intervention.
Research Focus and Grant Funding
RTFCCR funds interventional clinical trials worldwide, with emphasis on projects that:
- Improve therapeutic outcomes and patient quality of life
- Include patient partner involvement in research design and implementation
- Address key priority areas, including therapy optimization, disease burden, early detection, and early intervention
- Promote scalable and equitable approaches to cancer care
Programs and Initiatives
One of RTFCCR’s recent initiatives is the Early Career in Supportive Care Program, which supports early‑career investigators conducting supportive care research — focusing on prevention and management of adverse effects from cancer and its treatments. Grants offer significant multi‑year funding to help investigators build competitive research programs.
RTFCCR also collaborates with international partners to co‑fund trials like lung cancer recurrence projects and melanoma research, and participates in major oncology conferences to advance dialogue and innovation in the field.
Patient‑Partner Approach
A distinguishing feature of RTFCCR is its patient partner model, where patients, caregivers, and advocates help shape research priorities and review funding applications. This ensures that funded clinical trials address real patient needs and meaningful outcomes.
Impact and Global Reach
RTFCCR supports cancer research projects across many cancer types without geographic limits. For example, it has funded studies on frailty prevention in breast cancer survivors and helped enable international multi‑site trials.
Conclusion
The Rising Tide Foundation for Clinical Cancer Research plays a critical role in transforming cancer research by promoting innovative, patient‑centered clinical trials that aim to improve treatment, survivorship, and quality of life. Its global grants, strategic collaborations, and commitment to patient involvement make it a key force in advancing clinical cancer care.
For more information, visit here.
